403 related articles for article (PubMed ID: 19794494)
21. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
Suzuki N; Ichino M; Mihara S; Kaneko S; Sakane T
Arthritis Rheum; 1998 Feb; 41(2):344-53. PubMed ID: 9485093
[TBL] [Abstract][Full Text] [Related]
22. Membrane-bound and soluble Fas ligands have opposite functions in photoreceptor cell death following separation from the retinal pigment epithelium.
Matsumoto H; Murakami Y; Kataoka K; Notomi S; Mantopoulos D; Trichonas G; Miller JW; Gregory MS; Ksander BR; Marshak-Rothstein A; Vavvas DG
Cell Death Dis; 2015 Nov; 6(11):e1986. PubMed ID: 26583327
[TBL] [Abstract][Full Text] [Related]
23. Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing.
Siena L; Pace E; Ferraro M; Di Sano C; Melis M; Profita M; Spatafora M; Gjomarkaj M
Immunology; 2014 Feb; 141(2):242-55. PubMed ID: 24128051
[TBL] [Abstract][Full Text] [Related]
24. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
Takahashi T; Tanaka M; Brannan CI; Jenkins NA; Copeland NG; Suda T; Nagata S
Cell; 1994 Mar; 76(6):969-76. PubMed ID: 7511063
[TBL] [Abstract][Full Text] [Related]
25. Restraint stress of male mice induces apoptosis in spermatozoa and spermatogenic cells: role of the FasL/Fas system†.
Xiao B; Li X; Feng XY; Gong S; Li ZB; Zhang J; Yuan HJ; Tan JH
Biol Reprod; 2019 Jul; 101(1):235-247. PubMed ID: 31066896
[TBL] [Abstract][Full Text] [Related]
26. Soluble Fas ligand-susceptible "memory" cells in mice but not in human: potential role of soluble Fas ligand in deletion of auto-reactive cells.
Kim S; Ki JY; Lee TH; Suk K; Cha HS; Koh EM; Yagita H; Lee MS
Autoimmunity; 2002 Feb; 35(1):15-20. PubMed ID: 11908702
[TBL] [Abstract][Full Text] [Related]
27. Impact of loss of NF-κB1, NF-κB2 or c-REL on SLE-like autoimmune disease and lymphadenopathy in Fas(lpr/lpr) mutant mice.
Low JT; Hughes P; Lin A; Siebenlist U; Jain R; Yaprianto K; Gray DH; Gerondakis S; Strasser A; O'Reilly LA
Immunol Cell Biol; 2016 Jan; 94(1):66-78. PubMed ID: 26084385
[TBL] [Abstract][Full Text] [Related]
28. HSV-2 regulates monocyte inflammatory response via the Fas/FasL pathway.
Krzyzowska M; Baska P; Orlowski P; Zdanowski R; Winnicka A; Eriksson K; Stankiewicz W
PLoS One; 2013; 8(7):e70308. PubMed ID: 23922974
[TBL] [Abstract][Full Text] [Related]
29. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis.
Powell WC; Fingleton B; Wilson CL; Boothby M; Matrisian LM
Curr Biol; 1999 Dec 16-30; 9(24):1441-7. PubMed ID: 10607586
[TBL] [Abstract][Full Text] [Related]
30. Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity.
Medana I; Li Z; Flügel A; Tschopp J; Wekerle H; Neumann H
J Immunol; 2001 Jul; 167(2):674-81. PubMed ID: 11441070
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity.
Hughes PD; Belz GT; Fortner KA; Budd RC; Strasser A; Bouillet P
Immunity; 2008 Feb; 28(2):197-205. PubMed ID: 18275830
[TBL] [Abstract][Full Text] [Related]
32. TNF contributes to the immunopathology of perforin/Fas ligand double deficiency.
Cretney E; Street SE; Smyth MJ
Immunol Cell Biol; 2002 Oct; 80(5):436-40. PubMed ID: 12225379
[TBL] [Abstract][Full Text] [Related]
33. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.
Davidson WF; Haudenschild C; Kwon J; Williams MS
J Immunol; 2002 Dec; 169(11):6218-30. PubMed ID: 12444127
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand.
Knox PG; Milner AE; Green NK; Eliopoulos AG; Young LS
J Immunol; 2003 Jan; 170(2):677-85. PubMed ID: 12517928
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma.
Krishnan A; Fei F; Jones A; Busto P; Marshak-Rothstein A; Ksander BR; Gregory-Ksander M
J Immunol; 2016 Dec; 197(12):4626-4638. PubMed ID: 27849168
[TBL] [Abstract][Full Text] [Related]
36. Fas ligand (gld)- and Fas (lpr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils.
Fecho K; Cohen PL
J Leukoc Biol; 1998 Sep; 64(3):373-83. PubMed ID: 9738665
[TBL] [Abstract][Full Text] [Related]
37. Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis.
Wahlsten JL; Gitchell HL; Chan CC; Wiggert B; Caspi RR
J Immunol; 2000 Nov; 165(10):5480-6. PubMed ID: 11067900
[TBL] [Abstract][Full Text] [Related]
38. The FasLane to ocular pathology-metalloproteinase cleavage of membrane-bound FasL determines FasL function.
Gregory-Ksander M; Marshak-Rothstein A
J Leukoc Biol; 2021 Nov; 110(5):965-977. PubMed ID: 33565149
[TBL] [Abstract][Full Text] [Related]
39. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit T cell-mediated cytotoxicity by inhibiting Fas ligand expression.
Delgado M; Ganea D
J Immunol; 2000 Jul; 165(1):114-23. PubMed ID: 10861043
[TBL] [Abstract][Full Text] [Related]
40. Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells.
Mittelstadt PR; Ashwell JD
J Biol Chem; 1999 Jan; 274(5):3222-7. PubMed ID: 9915863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
